Unilever's $270M Bet on AI-Powered Beauty in Connecticut's Bio-Hub

NEW HAVEN, CT – May 28, 2026 – Unilever, the global consumer goods giant, announced a monumental $270 million investment to establish a new Global Innovation Center in New Haven, Connecticut. The state-of-the-art facility, slated to open by spring 2029, represents a strategic pivot for the company, anchoring its research and development for personal care, beauty, and wellbeing in one of the nation's fastest-growing bioscience clusters.

This move signals more than just a new building; it's a declaration of intent. By integrating advanced technology with deep scientific research, Unilever aims to redefine the pace and process of innovation, creating the next generation of products for its powerhouse brands like Dove, Vaseline, and Nutrafol. The center will replace the company's long-standing R&D facility in Trumbull, which has been operational since 1972, marking a significant shift into a new era of product development.

A Strategic Pivot to High-Tech Beauty

The New Haven center is a cornerstone of Unilever's strategy to become a more focused and agile company centered on its high-growth beauty and wellbeing portfolio. The facility is designed to be a hyper-connected hub where every stage of the innovation cycle—from molecular science and formulation to fragrance creation and packaging design—is housed under one roof.

"New Haven gets us to the future faster," said Herrish Patel, President of Unilever USA and CEO of Personal Care North America. "Our Global Innovation Center is where we'll innovate at the intersection of science, technology and culture — for the U.S. and for the world."

The center's foundation is built on a "digital-first" philosophy, powered by artificial intelligence and what the company describes as "emerging quantum capabilities." These technologies are not just buzzwords; they are tools intended to dramatically accelerate discovery. AI algorithms will sift through vast datasets to identify novel ingredients and predict consumer responses, while quantum computing holds the long-term promise of simulating molecular interactions to unlock entirely new materials for skincare and personal care.

Richard Slater, Unilever's Chief Research & Development Officer, emphasized the focus on integration and velocity. "Behind every Unilever product is world-leading science that delivers superior performance, combined with design, fragrance and sensory experiences that make our brands distinctive," he stated. "The real shift here is integration and speed: science, design and sensorials working as one, with AI and partnerships accelerating every stage of innovation."

Specific capabilities at the new hub will include a global center for skincare, a polycultural skin and hair center of excellence to address diverse consumer needs, a human performance lab for testing ingestibles, and an in-house Unilever Fragrance House, ensuring scent is integral to product creation from the very beginning.

Fueling Connecticut's Biosciences Boom

Unilever's decision to plant its flag in New Haven is a massive endorsement of the city's transformation into a premier bioscience hub. The region, already home to nearly half of Connecticut's biotech firms and major players like Pfizer and Alexion, offers a rich ecosystem of academic prowess, startup energy, and public support.

The new center will be strategically located within this cluster, providing Unilever's 300 employees with direct access to world-class research from nearby Yale University and a vibrant network of hundreds of life science companies. This proximity is designed to foster collaboration and spark innovation, particularly in areas where Unilever is deepening its expertise, such as skin biology, the microbiome, and the skin-brain axis.

Connecticut Governor Ned Lamont praised the investment as a landmark achievement for the state. "Unilever’s decision to make this investment in New Haven reaffirms Connecticut’s global reputation as a leader in innovation, research and development, and discovery," he said. "This innovation center will serve as an important foundational piece for this burgeoning hub that will not only strengthen New Haven’s existing tech centers but will also boost our innovation ecosystem statewide."

The state has actively cultivated this environment through significant investment. Connecticut's Bioscience Innovation Fund and a $100 million Innovation Clusters Program, which recently awarded $50.5 million to New Haven, have created a fertile ground for companies like Unilever. These initiatives, combined with R&D tax credits and a highly educated STEM workforce, make the state a powerful competitor to established hubs like Cambridge and New York.

Inside the Lab of the Future

The true innovation of the New Haven center may lie in its holistic approach to creation. By breaking down the traditional silos between scientific research, product design, and consumer insights, Unilever aims to create a fluid and rapid development pipeline. A team of perfumers, for example, will work alongside chemists and packaging designers from the initial concept stage, ensuring that the sensory experience is not an afterthought but a core component of the product's DNA.

The facility’s packaging innovation studio will incorporate real-time consumer feedback to fast-track the development of prototypes that are effective on both physical and digital shelves. This end-to-end integration is designed to shave months, if not years, off the traditional product development timeline.

This investment is not just about creating new lotions and shampoos faster. It is about pioneering a more sophisticated, science-led approach to personal care. By leveraging cutting-edge neuroscience, the company's scientists will explore how sensory attributes like texture and fragrance connect with emotional and behavioral responses, pushing the boundaries of what consumers can expect from their daily routines. The total combined public and private investment, exceeding $300 million, underscores the scale of this ambition as Unilever builds on the nearly $15 billion it has invested in its U.S. business over the past decade.